|
10.01.2017 16:10:00
|
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of DaVita Inc. (DVA)
NEW YORK, Jan. 10, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of the securities of DaVita Inc. ("DaVita" or the "Company") (NYSE: DVA). Such investors can obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/dva.
The investigation concerns whether DaVita and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.
On January 6, 2017, after market hours, the Wall Street Journal issued a report revealing that DaVita had received subpoenas from federal prosecutors asking for "the production of information related to charitable premium assistance" in regards to the Company's ties to the American Kidney Fund, a charity that helps patients pay for kidney dialysis. Following this news, DaVita stock dropped about 4% during intraday trading on January 9, 2017.
If you are aware of any facts relating to this investigation, or purchased DaVita shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/dva. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm's expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-davita-inc-dva-300388139.html
SOURCE Bronstein, Gewirtz & Grossman, LLC
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu DaVita HealthCare Partners Incmehr Nachrichten
|
14.02.25 |
NYSE-Handel: S&P 500 klettert (finanzen.at) | |
|
14.02.25 |
S&P 500-Handel aktuell: S&P 500 in der Gewinnzone (finanzen.at) | |
|
14.02.25 |
Zuversicht in New York: S&P 500 beginnt Sitzung mit Gewinnen (finanzen.at) | |
|
14.02.25 |
AKTIE IM FOKUS 2: FMC schwach - Davita überzeugt nicht, Hohe Sterblichkeit (dpa-AFX) | |
|
12.02.25 |
Ausblick: DaVita HealthCare Partners legt Quartalsergebnis vor (finanzen.net) | |
|
10.02.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel Gewinn hätte eine DaVita HealthCare Partners-Investition von vor 3 Jahren eingebracht (finanzen.at) | |
|
03.02.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel Gewinn hätte ein Investment in DaVita HealthCare Partners von vor einem Jahr abgeworfen (finanzen.at) | |
|
27.01.25 |
S&P 500-Papier DaVita HealthCare Partners-Aktie: So viel hätten Anleger an einem DaVita HealthCare Partners-Investment von vor 10 Jahren verdient (finanzen.at) |
Analysen zu DaVita HealthCare Partners Incmehr Analysen
Aktien in diesem Artikel
| DaVita HealthCare Partners Inc | 148,30 | -12,46% |
|
Letzte Top-Ranking Nachrichten
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.